Ademetionine 400 mg Tablet is a high-potential product, and Salvus Pharma is providing a unique business blueprint for our brand, Adysil 400, to our PCD Pharma franchise partners in Visakhapatnam.
Your Blueprint for a Dual-Revenue Business:
- Step 1: The Market Analysis The Visakhapatnam healthcare market has two major, high-growth segments: liver health (driven by lifestyle issues) and orthopedic/joint care (driven by an aging population). Adysil 400 is uniquely positioned to serve both.
- Step 2: Your Target Audience (Dual-Specialty)
- Target 1 (Gastro): Gastroenterologists and Hepatologists who require a trusted hepato-protectant for liver support.
- Target 2 (Ortho): Orthopedic Surgeons and Rheumatologists who prescribe chondroprotective agents for osteoarthritis and joint health.
- Step 3: Your Tools for Success (The Salvus Pharma Toolkit) We provide exclusive monopoly rights for Visakhapatnam, allowing you to dominate both niches. You will receive specialized marketing materials for both gastro and ortho specialists, along with our WHO-GMP quality guarantee.
- Step 4: Build Your Business This is a rare opportunity to capture two distinct, high-value markets with a single product, doubling your revenue potential.
Build Your Dual-Specialty Franchise: To learn more about the Ademetionine 400 mg PCD franchise, contact Salvus Pharma today. Contact Us: Call +91 9888902349 or email marketing@salvuspharma.in.
